Table 3: Adverse events during single-dosed esomeprazole- and pantoprazole-based triple therapies.

Adverse eventsEAC group (n = 208)PAC group (n = 244)P value

Diarrhea7 (3.4%)10 (4.1%).131
Constipation1 (0.5%)2 (0.8%)1.000
Abdominal pain3 (1.4%)9 (3.7%).241
Anorexia1 (0.5%)3 (1.2%).633
Nausea7 (3.4%)8 (3.3%)1.000
Vomiting1 (0.5%)4 (1.6%).388
Skin rash0 (0%)5 (2%).069
Dizziness12 (5.8%)11 (4.5%).519
Headache2 (1%)8 (3.3%).196
Taste perversion32 (15.4%)29 (11.9%).209
Fatigue10 (4.8%)6 (2.5%).198